tiprankstipranks
Trending News
More News >
Oncolys BioPharma, Inc. (JP:4588)
:4588
Japanese Market
Advertisement

Oncolys BioPharma, Inc. (4588) Ratios

Compare
0 Followers

Oncolys BioPharma, Inc. Ratios

JP:4588's free cash flow for Q4 2024 was ¥0.00. For the 2024 fiscal year, JP:4588's free cash flow was decreased by ¥ and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
11.02 5.17 8.11 9.76 6.13
Quick Ratio
11.00 5.15 8.04 9.73 6.11
Cash Ratio
8.38 3.40 5.32 8.03 4.98
Solvency Ratio
-5.63 -3.42 -2.33 -2.31 -2.64
Operating Cash Flow Ratio
0.00 -3.53 -5.34 -4.05 -3.53
Short-Term Operating Cash Flow Coverage
0.00 -10.46 -7.54 -7.29 -9.77
Net Current Asset Value
¥ 1.87B¥ 1.39B¥ 2.12B¥ 3.50B¥ 1.75B
Leverage Ratios
Debt-to-Assets Ratio
0.12 0.15 0.15 0.12 0.19
Debt-to-Equity Ratio
0.15 0.21 0.18 0.14 0.26
Debt-to-Capital Ratio
0.13 0.18 0.15 0.12 0.21
Long-Term Debt-to-Capital Ratio
0.07 0.10 0.07 0.07 0.15
Financial Leverage Ratio
1.19 1.38 1.23 1.19 1.40
Debt Service Coverage Ratio
-15.93 -14.71 -4.94 -6.60 -13.53
Interest Coverage Ratio
-459.65 -535.81 -305.32 -348.90 -401.60
Debt to Market Cap
0.02 0.03 0.04 0.06 0.02
Interest Debt Per Share
11.80 17.91 22.95 30.01 36.77
Net Debt to EBITDA
0.68 0.50 1.15 1.84 0.74
Profitability Margins
Gross Profit Margin
99.97%48.55%34.67%30.94%75.15%
EBIT Margin
-6660.78%-3064.78%-116.99%-250.20%-664.33%
EBITDA Margin
-6658.27%-3061.15%-116.90%-249.19%-662.77%
Operating Profit Margin
-6652.22%-3061.62%-123.39%-226.39%-533.03%
Pretax Profit Margin
-6782.16%-3070.49%-117.40%-250.85%-665.66%
Net Profit Margin
-6793.90%-3075.14%-117.70%-251.43%-666.84%
Continuous Operations Profit Margin
-6793.90%-3075.14%-117.70%-251.43%-666.84%
Net Income Per EBT
100.17%100.15%100.26%100.23%100.18%
EBT Per EBIT
101.95%100.29%95.14%110.80%124.88%
Return on Assets (ROA)
-92.13%-95.00%-43.34%-37.64%-74.92%
Return on Equity (ROE)
-105.65%-131.50%-53.21%-44.95%-104.58%
Return on Capital Employed (ROCE)
-98.93%-116.12%-51.71%-37.67%-70.33%
Return on Invested Capital (ROIC)
-93.48%-107.54%-47.16%-35.53%-66.22%
Return on Tangible Assets
-92.13%-95.00%-43.34%-37.64%-74.94%
Earnings Yield
-13.75%-19.21%-12.58%-18.09%-9.69%
Efficiency Ratios
Receivables Turnover
0.14 0.62 3.07 1.82 4.45
Payables Turnover
0.00 0.17 10.48 4.18 0.00
Inventory Turnover
0.19 6.07 26.30 38.07 7.45
Fixed Asset Turnover
82.37 0.00 46.16 30.28 7.38
Asset Turnover
0.01 0.03 0.37 0.15 0.11
Working Capital Turnover Ratio
0.01 0.03 0.32 0.22 0.12
Cash Conversion Cycle
4.51K -1.53K 98.10 122.24 130.98
Days of Sales Outstanding
2.63K 589.12 119.05 200.05 82.02
Days of Inventory Outstanding
1.88K 60.12 13.88 9.59 48.96
Days of Payables Outstanding
0.00 2.18K 34.83 87.40 0.00
Operating Cycle
4.51K 649.24 132.93 209.64 130.98
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -75.12 -99.10 -102.97 -101.81
Free Cash Flow Per Share
0.00 -75.44 -99.18 -103.06 -102.00
CapEx Per Share
0.00 0.32 0.08 0.08 0.19
Free Cash Flow to Operating Cash Flow
0.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 -235.13 -1.26K -1.21K -542.67
Capital Expenditure Coverage Ratio
0.00 -235.13 -1.26K -1.21K -542.67
Operating Cash Flow Coverage Ratio
0.00 -4.24 -4.36 -3.46 -2.79
Operating Cash Flow to Sales Ratio
0.00 -21.21 -1.76 -2.71 -4.66
Free Cash Flow Yield
0.00%-13.30%-18.82%-19.52%-6.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-7.26 -5.21 -7.95 -5.53 -10.32
Price-to-Sales (P/S) Ratio
493.30 160.08 9.35 13.90 68.85
Price-to-Book (P/B) Ratio
7.98 6.85 4.23 2.49 10.80
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -7.52 -5.31 -5.12 -14.74
Price-to-Operating Cash Flow Ratio
0.00 -7.55 -5.32 -5.13 -14.76
Price-to-Earnings Growth (PEG) Ratio
0.39 -0.08 0.26 0.16 -0.08
Price-to-Fair Value
7.98 6.85 4.23 2.49 10.80
Enterprise Value Multiple
-6.73 -4.73 -6.85 -3.74 -9.65
Enterprise Value
14.09B 9.12B 7.81B 5.98B 20.09B
EV to EBITDA
-6.74 -4.73 -6.85 -3.74 -9.65
EV to Sales
448.81 144.65 8.00 9.31 63.94
EV to Free Cash Flow
0.00 -6.79 -4.55 -3.43 -13.68
EV to Operating Cash Flow
0.00 -6.82 -4.55 -3.43 -13.71
Tangible Book Value Per Share
78.09 82.83 124.62 212.47 139.16
Shareholders’ Equity Per Share
78.09 82.83 124.62 212.47 139.20
Tax and Other Ratios
Effective Tax Rate
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
1.26 3.54 56.34 37.98 21.83
Net Income Per Share
-85.80 -108.92 -66.31 -95.50 -145.58
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
1.02 1.00 1.00 1.00 1.00
Research & Development to Revenue
47.65 21.45 0.97 1.28 3.14
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.82 0.16 0.06 0.33 1.20
Income Quality
0.00 0.69 1.50 1.08 0.70
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis